Idarubicin v daunorubicin: preclinical and clinical pharmacokinetic studies
Speth, P.A.; Minderman, H.; Haanen, C.
Seminars in Oncology 16(1 Suppl 2: 2-9
1989
ISSN/ISBN: 0093-7754 PMID: 2648580 Document Number: 326601
Document emailed within 1 workday
Related Documents
Masaoka, T.; Ogawa, M.; Yamada, K.; Kimura, K.; Ohhashi, Y. 1993: A late phase Ii comparative study of idarubicin + cytarabine and daunorubicin + cytarabine in adult patients with acute non-lymphocytic leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(13): 1995-2005Fujita, H.; Ogawa, M.; Masaoka, T.; Yamada, K.; Kimura, K. 1992: A pharmacokinetic study of idarubicin hydrochloride, a new anthracycline anti-tumor drug, in patients with acute leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(6): 791-798
Mandelli, F.; Petti, M.C.; Ardia, A.; Di Pietro, N.; Di Raimondo, F.; Ganzina, F.; Falconi, E.; Geraci, E.; Ladogana, S.; Latagliata, R. 1991: A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA European Journal of Cancer 27(6): 750-755
Curtis, J.E.; Minden, M.D.; Minkin, S.; McCulloch, E.A. 1995: Sensitivities of AML blast stem cells to idarubicin and daunorubicin: a comparison with normal hematopoietic progenitors Leukemia 9(3): 396-404
Vogler, W.R.; Velez-Garcia, E.; Omura, G.; Raney, M. 1989: A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia Seminars in Oncology 16(1 Suppl 2: 21-24
Tamassia, V.; Pacciarini, M.A.; Moro, E.; Piazza, E.; Vago, G.; Libretti, A. 1987: Pharmacokinetic study of intravenous and oral idarubicin in cancer patients International Journal of Clinical Pharmacology Research 7(5): 419-426
Mankhetkorn, S.; Dubru, F.; Hesschenbrouck, J.; Fiallo, M.; Garnier-Suillerot, A. 1996: Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells Molecular Pharmacology 49(3): 532-539
Wiernik, P.H.; Schimpff, S.C.; Schiffer, C.A.; Lichtenfeld, J.L.; Aisner, J.; O'connell, M.J.; Fortner, C. 1976: Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia Cancer Treatment Reports 60(1): 41-53
Varma, K.J.; Powers, T.E.; Powers, J.D. 1987: Single- and repeat-dose pharmacokinetic studies of chloramphenicol in horses: values and limitations of pharmacokinetic studies in predicting dosage regimens American Journal of Veterinary Research 48(3): 403-406
Smith, A.C.; Barrett, D.; Stedham, M.A.; el-Hawari, M.; Kastello, M.D.; Grieshaber, C.K.; Boyd, M.R. 1987: Preclinical toxicology studies of 4-ipomeanol: a novel candidate for clinical evaluation in lung cancer Cancer Treatment Reports 71(12): 1157-1164
Sato, Y.; Iwata, S.; Akita, H.; Sunakawa, K. 1991: Pharmacokinetic and clinical studies on cefpirome in pediatrics Japanese Journal of Antibiotics 44(2): 168-183
Muggia, F.M.; Creaven, P.J.; Hansen, H.H.; Cohen, M.H.; Selawry, O.S. 1972: Phase i clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies Cancer ChemoTherapy Reports 56(4): 515-521
Tajima, T.; Kobayashi, M.; Hata, M.; Negishi, S.; Kubota, K.; Iitsuka, T.; Hagiwara, N.; Kudou, S.; Nakayama, T.; Abe, T. 1995: Pharmacokinetic, bacteriological, and clinical studies on SY5555 in children Japanese Journal of Antibiotics 48(1): 31-40
Hooper, W.D.; Dickinson, R.G.; Dunstan, P.R.; Pendlebury, S.C.; Eadie, M.J. 1987: Oxcarbazepine: preliminary clinical and pharmacokinetic studies on a new anticonvulsant Clinical and Experimental Neurology 24: 105-112
Toyonaga, Y.; Ishihara, T.; Tezuka, T.; Sano, T.; Nakamura, H. 1993: Pharmacokinetic and clinical studies of S-1108 in the pediatric field Japanese Journal of Antibiotics 46(11): 991-1002
Nakazawa, S.; Sato, H.; Hirama, Y.; Narita, A.; Matsumoto, K.; Nakazawa, S.; Suzuki, H.; Nakanishi, Y.; Chikaoka, H.; Niino, K. 1989: Pharmacokinetic and clinical studies on cefmenoxime in newborn infants Japanese Journal of Antibiotics 42(12): 2627-2640
Fujii, R.; Meguro, H.; Arimasu, O.; Mashiko, J.; Kobayashi, M.; Nakazawa, S.; Satoh, H.; Narita, A.; Matsumoto, K.; Suzuki, H. 1986: Pharmacokinetic and clinical studies on cefuzonam in the pediatric field Japanese Journal of Antibiotics 39(10): 2601-2619
Kukes, V.G.; Volkov, R.I.; Ibadova, D.; Shokhor, V.I. 1985: Results of the pharmacokinetic, pharmacodynamic and clinical studies of digoxin use Terapevticheskii Arkhiv 57(12): 59-62
Hayasaki, M.; Hanabayashi, T.; Ri, J.; Takada, Y.; Ito, K.; Noda, K.; Iida, M.; Chan, C.; Yamada, Y.; Osugi, S. 1986: Pharmacokinetic and clinical studies of cefotiam in the perinatal period Japanese Journal of Antibiotics 39(9): 2497-2518
Cho, N.; Fukunaga, K.; Kunii, K. 1986: Pharmacokinetic and clinical studies of ceftazidime in perinatal period Japanese Journal of Antibiotics 39(8): 2225-2246